Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.35 |
| ▸ | CA1 | P00915 | 4/20 | 0.35 |
| ▸ | CA2 | P00918 | 4/20 | 0.35 |
| ▸ | CA9 | Q16790 | 4/20 | 0.35 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.32 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.32 |
| ▸ | PDK2 | Q15119 | 4/20 | 0.31 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.31 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | CASP1 | P29466 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23447794 | 0.96 | CA12 (0.36) | CA12CA1CA2CA9ENPP3 | |
| SCHEMBL23447696 | 0.96 | CA12 (0.35) | CA12CA1CA2CA9PDK2 | |
| SCHEMBL23448183 | 0.95 | CA12 (0.32) | CA12CA1CA2CA9ENPP3 | |
| SCHEMBL25463886 | 0.95 | PDK2 (0.33) | PDK2GPR84L3MBTL1 | |
| SCHEMBL23448727 | 0.94 | CA12 (0.33) | CA12CA1CA2CA9PDK2 | |
| SCHEMBL26281804 | 0.94 | PDK2 (0.32) | PDK2GPR84ALDH1A1HPGDTSHR | |
| SCHEMBL24838918 | 0.93 | CA12 (0.32) | CA12CA1CA2CA9 | |
| SCHEMBL23239322 | 0.93 | CA12 (0.36) | CA12CA1CA2CA9ENPP3 | |
| SCHEMBL23448803 | 0.92 | CA12 (0.38) | CA12CA1CA2CA9ENPP3 | |
| SCHEMBL26063542 | 0.92 | GPR84 (0.31) | PDK2GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230002420-A1 | ORGANIC LIGHT-EMITTING ELEMENT | LG CHEM, LTD. (KR) | 2023-01-05 | — | — | US | disclosed |
| WO-2021107737-A1 | ORGANIC LIGHT-EMITTING ELEMENT | 주식회사 엘지화학 | 2021-06-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230002420-A1 | ORGANIC LIGHT-EMITTING ELEMENT | CYBA, CRY1, CYP1A1 | CA12 2383/4885CA1 2539/4885CA2 2579/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.